01-22-2021Cross-posted from FDA Newsroom[Yesterday] the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a…
07-14-2020Cross-posted from U.S. Food and Drug Administration[On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of…
04-02-2020Cross-posted from U.S. Food and Drug AdministrationStatement from: Director - Center for Biologics Evaluation and Research (CBER), Peter Marks M.D., PhD.As…
02-06-2020Cross-posted from U.S. Food and Drug Administration, Statement from Commissioner of Food and Drugs - Food and Drug Administration Stephen M. Hahn M.D.On Friday…